Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v10-EN | Version v2-FR | |
---|---|---|
Language | English | French |
Date Updated | 2023-01-07 | 2022-11-10 |
Drug Identification Number | 02378426 | 02378426 |
Brand name | LOVENOX | LOVENOX |
Common or Proper name | enoxaparin sodium | enoxaparin sodium |
Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
Ingredients | ENOXAPARIN SODIUM | ENOXAPARIN SODIUM |
Strength(s) | 60MG | 60MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | pre-filled syringes 27 G in packs of 10 syringes per carton, 2 prefilled syringes with protective shield per blister, each in individual blister pack | pre-filled syringes 27 G in packs of 10 syringes per carton, 2 prefilled syringes with protective shield per blister, each in individual blister pack |
ATC code | B01AB | B01AB |
ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-11-11 | 2022-11-11 |
Actual start date | 2022-11-11 | |
Estimated end date | 2023-01-06 | 2022-12-12 |
Actual end date | 2023-01-06 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments |